Durham biotech startup founded by Duke grad raises nearly $1M in equity
DURHAM – Tavros Therapeutics, an emerging biotechnology company based out of Durham, has raised nearly $1 million in equity, according to a recent securities filing, and is working to discover “a new frontier” in oncology therapy.
